Project Grant HDTRA12310020

The National Center for Disease Control and Public Health in Georgia received a $719,500 Project Grant award from the Defense Threat Reduction Agency on January 25, 2022 to support ecological and epidemiological investigation of Crimean-Congo hemorrhagic fever virus through January 24, 2025. The funding supports research under the Scientific Research - Combating Weapons of Mass Destruction federal grant program (CFDA 12.351), which aims to advance fundamental knowledge in sciences supporting the...

The federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) provides $8,536,000 in funding to the African Field Epidemiology Network Ltd. (AFENET) to implement the "REINFORCING IMMUNIZATION SYSTEMS FOR CONSEQUENTIAL GEOGRAPHIES (RISE4CGS) IN DRC, ETHIOPIA AND NIGERIA" project. This 5-year cooperative agreement, which commenced on September 30, 2024, aims to strengthen...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $558,501 to Albert Einstein College of Medicine to conduct research on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV). The overarching goal is to address critical gaps in understanding the architecture, assembly, and functions of the CCHFV glycoprotein components and complexes, and their roles in virion...

This $7,018,665 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response program (CFDA 93.354) will enable the New York State Department of Health, through its contract with Health Research, Inc., to strengthen public health emergency preparedness and response capabilities across New York. The funding will be used to enhance the state's incident management, community resilience, information management, countermeasures and...

This federal Project Grant award, valued at $685,980.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to isolate broadly protective monoclonal antibodies for Crimean-Congo Hemorrhagic Fever (CCHF). The primary objectives are to: 1) Develop a cohort of CCHF survivors and isolate a panel of monoclonal antibodies against the CCHF virus envelope; 2) Test the efficacy of the...

The Centers for Disease Control and Prevention (CDC) awarded a $3,710,204 Cooperative Agreement to Humana People To People Congo (Hpp-Congo) under the Global AIDS (CFDA 93.067) program. This 5-year award, running from September 2024 to September 2029, will support the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project, which aims to address HIV/AIDS prevention, testing, treatment, and care in Kinshasa, Democratic Republic of the Congo. Hpp-Congo, a non-profit organization...

This $1,000,000 Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), aims to strengthen Ukraine's public health data management and analysis capabilities to support evidence-based HIV/AIDS prevention and treatment decision-making. The primary awardee, PATH, a global health nonprofit organization, will collaborate with Ukraine's Public Health Center to enhance national HIV data quality, accessibility, and...

This federal Cooperative Agreement award, totaling $15,754,880.00 and funded by the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283), aims to strengthen national health laboratory services and partnerships in Uganda for quality HIV-related testing and other diagnostics. The award, which has an end date of September 29, 2029, will support improved laboratory coordination and management under the President's Emergency Plan for AIDS...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $4,018,665 Cooperative Agreement under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program to the Health Services Kentucky Cabinet For. The funding will enable Kentucky's Department for Public Health (DPH), in coordination with local, state, and federal partners, to strengthen and enhance strategies and activities to rapidly mobilize and...

This $600,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) will support Jhpiego Corp in strengthening public health emergency preparedness and management platforms in Liberia. The grant, with a performance period from Sep 30, 2024 to Sep 29, 2029, aims to achieve global health security by building local capacity for public health emergency response. As a global health...